Alterations in the expression profiles of TACR2 and TACR3 genes have been reported for different pathologies, e.g., polycystic ovarian syndrome [90], leiomyoma [91], oral carcinoma [21], or breast cancer [92]. The gene discussed is TACR3; the disease is leiomyoma.